1 Fully Automated Coagulometer Market Overview
1.1 Product Overview and Scope of Fully Automated Coagulometer
1.2 Fully Automated Coagulometer Segment by Type
1.2.1 Global Fully Automated Coagulometer Market Value Comparison by Type (2023-2029)
1.2.2 Detached
1.2.3 Desktop
1.2.4 Handheld
1.3 Fully Automated Coagulometer Segment by Application
1.3.1 Global Fully Automated Coagulometer Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Others
1.4 Global Fully Automated Coagulometer Market Size Estimates and Forecasts
1.4.1 Global Fully Automated Coagulometer Revenue 2018-2029
1.4.2 Global Fully Automated Coagulometer Sales 2018-2029
1.4.3 Global Fully Automated Coagulometer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Fully Automated Coagulometer Market Competition by Manufacturers
2.1 Global Fully Automated Coagulometer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fully Automated Coagulometer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fully Automated Coagulometer Average Price by Manufacturers (2018-2023)
2.4 Global Fully Automated Coagulometer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Fully Automated Coagulometer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fully Automated Coagulometer, Product Type & Application
2.7 Fully Automated Coagulometer Market Competitive Situation and Trends
2.7.1 Fully Automated Coagulometer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fully Automated Coagulometer Players Market Share by Revenue
2.7.3 Global Fully Automated Coagulometer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fully Automated Coagulometer Retrospective Market Scenario by Region
3.1 Global Fully Automated Coagulometer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Fully Automated Coagulometer Global Fully Automated Coagulometer Sales by Region: 2018-2029
3.2.1 Global Fully Automated Coagulometer Sales by Region: 2018-2023
3.2.2 Global Fully Automated Coagulometer Sales by Region: 2024-2029
3.3 Global Fully Automated Coagulometer Global Fully Automated Coagulometer Revenue by Region: 2018-2029
3.3.1 Global Fully Automated Coagulometer Revenue by Region: 2018-2023
3.3.2 Global Fully Automated Coagulometer Revenue by Region: 2024-2029
3.4 North America Fully Automated Coagulometer Market Facts & Figures by Country
3.4.1 North America Fully Automated Coagulometer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Fully Automated Coagulometer Sales by Country (2018-2029)
3.4.3 North America Fully Automated Coagulometer Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fully Automated Coagulometer Market Facts & Figures by Country
3.5.1 Europe Fully Automated Coagulometer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Fully Automated Coagulometer Sales by Country (2018-2029)
3.5.3 Europe Fully Automated Coagulometer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fully Automated Coagulometer Market Facts & Figures by Country
3.6.1 Asia Pacific Fully Automated Coagulometer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Fully Automated Coagulometer Sales by Country (2018-2029)
3.6.3 Asia Pacific Fully Automated Coagulometer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fully Automated Coagulometer Market Facts & Figures by Country
3.7.1 Latin America Fully Automated Coagulometer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Fully Automated Coagulometer Sales by Country (2018-2029)
3.7.3 Latin America Fully Automated Coagulometer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fully Automated Coagulometer Market Facts & Figures by Country
3.8.1 Middle East and Africa Fully Automated Coagulometer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Fully Automated Coagulometer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Fully Automated Coagulometer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fully Automated Coagulometer Sales by Type (2018-2029)
4.1.1 Global Fully Automated Coagulometer Sales by Type (2018-2023)
4.1.2 Global Fully Automated Coagulometer Sales by Type (2024-2029)
4.1.3 Global Fully Automated Coagulometer Sales Market Share by Type (2018-2029)
4.2 Global Fully Automated Coagulometer Revenue by Type (2018-2029)
4.2.1 Global Fully Automated Coagulometer Revenue by Type (2018-2023)
4.2.2 Global Fully Automated Coagulometer Revenue by Type (2024-2029)
4.2.3 Global Fully Automated Coagulometer Revenue Market Share by Type (2018-2029)
4.3 Global Fully Automated Coagulometer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Fully Automated Coagulometer Sales by Application (2018-2029)
5.1.1 Global Fully Automated Coagulometer Sales by Application (2018-2023)
5.1.2 Global Fully Automated Coagulometer Sales by Application (2024-2029)
5.1.3 Global Fully Automated Coagulometer Sales Market Share by Application (2018-2029)
5.2 Global Fully Automated Coagulometer Revenue by Application (2018-2029)
5.2.1 Global Fully Automated Coagulometer Revenue by Application (2018-2023)
5.2.2 Global Fully Automated Coagulometer Revenue by Application (2024-2029)
5.2.3 Global Fully Automated Coagulometer Revenue Market Share by Application (2018-2029)
5.3 Global Fully Automated Coagulometer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Fully Automated Coagulometer Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 F. Hoffmann-La Roche Ltd. Fully Automated Coagulometer Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Grifols, S.A.
6.3.1 Grifols, S.A. Corporation Information
6.3.2 Grifols, S.A. Description and Business Overview
6.3.3 Grifols, S.A. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols, S.A. Fully Automated Coagulometer Product Portfolio
6.3.5 Grifols, S.A. Recent Developments/Updates
6.4 Erba Mannheim
6.4.1 Erba Mannheim Corporation Information
6.4.2 Erba Mannheim Description and Business Overview
6.4.3 Erba Mannheim Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Erba Mannheim Fully Automated Coagulometer Product Portfolio
6.4.5 Erba Mannheim Recent Developments/Updates
6.5 Instrumentation Laboratory (Werfen Company)
6.5.1 Instrumentation Laboratory (Werfen Company) Corporation Information
6.5.2 Instrumentation Laboratory (Werfen Company) Description and Business Overview
6.5.3 Instrumentation Laboratory (Werfen Company) Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Instrumentation Laboratory (Werfen Company) Fully Automated Coagulometer Product Portfolio
6.5.5 Instrumentation Laboratory (Werfen Company) Recent Developments/Updates
6.6 Haemonetics Corporation
6.6.1 Haemonetics Corporation Corporation Information
6.6.2 Haemonetics Corporation Description and Business Overview
6.6.3 Haemonetics Corporation Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Haemonetics Corporation Fully Automated Coagulometer Product Portfolio
6.6.5 Haemonetics Corporation Recent Developments/Updates
6.7 HYCEL MEDICAL
6.6.1 HYCEL MEDICAL Corporation Information
6.6.2 HYCEL MEDICAL Description and Business Overview
6.6.3 HYCEL MEDICAL Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HYCEL MEDICAL Fully Automated Coagulometer Product Portfolio
6.7.5 HYCEL MEDICAL Recent Developments/Updates
6.8 Scientifica Tecnologie Biomediche
6.8.1 Scientifica Tecnologie Biomediche Corporation Information
6.8.2 Scientifica Tecnologie Biomediche Description and Business Overview
6.8.3 Scientifica Tecnologie Biomediche Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Scientifica Tecnologie Biomediche Fully Automated Coagulometer Product Portfolio
6.8.5 Scientifica Tecnologie Biomediche Recent Developments/Updates
6.9 Bio Group Medical System
6.9.1 Bio Group Medical System Corporation Information
6.9.2 Bio Group Medical System Description and Business Overview
6.9.3 Bio Group Medical System Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bio Group Medical System Fully Automated Coagulometer Product Portfolio
6.9.5 Bio Group Medical System Recent Developments/Updates
6.10 iLine Microsystems
6.10.1 iLine Microsystems Corporation Information
6.10.2 iLine Microsystems Description and Business Overview
6.10.3 iLine Microsystems Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.10.4 iLine Microsystems Fully Automated Coagulometer Product Portfolio
6.10.5 iLine Microsystems Recent Developments/Updates
6.11 Maccura Biotechnology Co., Ltd.
6.11.1 Maccura Biotechnology Co., Ltd. Corporation Information
6.11.2 Maccura Biotechnology Co., Ltd. Fully Automated Coagulometer Description and Business Overview
6.11.3 Maccura Biotechnology Co., Ltd. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Maccura Biotechnology Co., Ltd. Fully Automated Coagulometer Product Portfolio
6.11.5 Maccura Biotechnology Co., Ltd. Recent Developments/Updates
6.12 Horiba, Ltd.
6.12.1 Horiba, Ltd. Corporation Information
6.12.2 Horiba, Ltd. Fully Automated Coagulometer Description and Business Overview
6.12.3 Horiba, Ltd. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Horiba, Ltd. Fully Automated Coagulometer Product Portfolio
6.12.5 Horiba, Ltd. Recent Developments/Updates
6.13 Accriva Diagnostics
6.13.1 Accriva Diagnostics Corporation Information
6.13.2 Accriva Diagnostics Fully Automated Coagulometer Description and Business Overview
6.13.3 Accriva Diagnostics Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Accriva Diagnostics Fully Automated Coagulometer Product Portfolio
6.13.5 Accriva Diagnostics Recent Developments/Updates
6.14 HemoSonics LLC.
6.14.1 HemoSonics LLC. Corporation Information
6.14.2 HemoSonics LLC. Fully Automated Coagulometer Description and Business Overview
6.14.3 HemoSonics LLC. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.14.4 HemoSonics LLC. Fully Automated Coagulometer Product Portfolio
6.14.5 HemoSonics LLC. Recent Developments/Updates
6.15 Meril Life Sciences Pvt. Ltd.
6.15.1 Meril Life Sciences Pvt. Ltd. Corporation Information
6.15.2 Meril Life Sciences Pvt. Ltd. Fully Automated Coagulometer Description and Business Overview
6.15.3 Meril Life Sciences Pvt. Ltd. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Meril Life Sciences Pvt. Ltd. Fully Automated Coagulometer Product Portfolio
6.15.5 Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
6.16 Helena Biosciences
6.16.1 Helena Biosciences Corporation Information
6.16.2 Helena Biosciences Fully Automated Coagulometer Description and Business Overview
6.16.3 Helena Biosciences Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Helena Biosciences Fully Automated Coagulometer Product Portfolio
6.16.5 Helena Biosciences Recent Developments/Updates
6.17 Merlin Medical
6.17.1 Merlin Medical Corporation Information
6.17.2 Merlin Medical Fully Automated Coagulometer Description and Business Overview
6.17.3 Merlin Medical Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Merlin Medical Fully Automated Coagulometer Product Portfolio
6.17.5 Merlin Medical Recent Developments/Updates
6.18 Erba Mannheim
6.18.1 Erba Mannheim Corporation Information
6.18.2 Erba Mannheim Fully Automated Coagulometer Description and Business Overview
6.18.3 Erba Mannheim Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Erba Mannheim Fully Automated Coagulometer Product Portfolio
6.18.5 Erba Mannheim Recent Developments/Updates
6.19 Rayto Life and Analytical Sciences Co.,Ltd.
6.19.1 Rayto Life and Analytical Sciences Co.,Ltd. Corporation Information
6.19.2 Rayto Life and Analytical Sciences Co.,Ltd. Fully Automated Coagulometer Description and Business Overview
6.19.3 Rayto Life and Analytical Sciences Co.,Ltd. Fully Automated Coagulometer Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Rayto Life and Analytical Sciences Co.,Ltd. Fully Automated Coagulometer Product Portfolio
6.19.5 Rayto Life and Analytical Sciences Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fully Automated Coagulometer Industry Chain Analysis
7.2 Fully Automated Coagulometer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fully Automated Coagulometer Production Mode & Process
7.4 Fully Automated Coagulometer Sales and Marketing
7.4.1 Fully Automated Coagulometer Sales Channels
7.4.2 Fully Automated Coagulometer Distributors
7.5 Fully Automated Coagulometer Customers
8 Fully Automated Coagulometer Market Dynamics
8.1 Fully Automated Coagulometer Industry Trends
8.2 Fully Automated Coagulometer Market Drivers
8.3 Fully Automated Coagulometer Market Challenges
8.4 Fully Automated Coagulometer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
※参考情報 全自動凝固検査装置とは、血液の凝固機能を正確かつ迅速に測定するための装置です。これにより、患者の状態を把握し、適切な治療を行うための情報を提供することができます。この装置は、血液中の凝固因子の機能評価や、抗凝固療法のモニタリングに不可欠な役割を果たします。 全自動凝固検査装置の最大の特徴は、その自動化のレベルです。複雑な手作業を省き、分析プロセスを全自動で行うことで、結果の再現性と正確性が大幅に向上します。また、試薬の添加や測定条件の設定、データの解析や報告書の作成までを一貫して行う機能を持ち、医療現場の効率化に寄与しています。 この装置にはいくつかの種類があります。一般的に、光凝固法、電気抵抗法、回転粘度法などの異なる測定原理を採用した機器があります。光凝固法では、血液の凝固に伴う光の透過度の変化を測定し、凝固速度を評価します。電気抵抗法では、血液中の細胞成分や凝固因子が試薬と反応する際の導電率を測定することで、固まるスピードを知ることができます。回転粘度法は、血液の粘性変化を基に凝固の過程を評価する方法です。 用途については、主に病院や診療所での臨床検査で利用されており、手術前の患者の凝固機能評価、血液疾患の診断、抗凝固薬の効果を測定する目的で使われます。例えば、心房細動の患者や静脈血栓症のリスクを持つ患者には、抗凝固薬を使用することが多く、この際には定期的な凝固機能検査が必要となります。このような場面で全自動凝固検査装置が活躍し、患者管理の質を向上させています。 さらに、全自動凝固検査装置は、質の高い医療サービスを提供するための一環として、テクノロジーの進展とも密接に関連しています。デジタル化の進展により、測定データは電子カルテと連携し、リアルタイムで医師に情報を提供することが可能となります。また、AI技術の導入によって、過去のデータからの学習を基にした凝固リスクの予測や、異常値の検知が行われることも期待されています。 このように、全自動凝固検査装置は現代の医療現場において欠かせないツールであり、その significant な進化は、患者の治療における正確性と迅速性を高めています。今後もさらなる技術革新により、より精密で効率的な検査が可能になることが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer